Phase 3 Readout~month
Phase 3 Topline: A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelo
- Drug
- switching
- Indication
- Chronic Hepatitis D
Other upcoming events for MIRM
Phase 2 ReadoutPhase 2 Readout: volixibat
Phase 3 ReadoutPhase 3 Topline: Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Mara
Phase 2 ReadoutPhase 2 Readout: volixibat
Patent ExpiryPatent/Exclusivity Expiry: CTEXLI
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open-label, Multicenter, Phase 3 Trial Evaluating Brelovitug vs Delayed Treatment for
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.